ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pain and patient outcomes"

  • Abstract Number: 2211 • 2017 ACR/ARHP Annual Meeting

    Investigation of Self-Reported Painful Joint Count As an Outcome Measure in Hand Osteoarthritis

    F.P.B. Kroon1, J.L. van der Plas1, S. van Beest1, W. Damman1 and M. Kloppenburg1,2, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Hand osteoarthritis (OA) research is in need of disease-specific validated instruments to measure patient-reported outcomes. Self-reported painful joint count (PJC) could be useful to…
  • Abstract Number: 741 • 2015 ACR/ARHP Annual Meeting

    Satisfaction and Impact Associated with the Addition of Belimumab to Systemic Lupus  Erythematosus (SLE) Treatment: A Cross-Sectional Survey of US Rheumatologists and Their Patients

    Katie Pascoe1, Steve Lobosco2, David Bell3, Ben Hoskin3, Sulabha Ramachandran4, Bonnie Pobiner5 and David Chang6, 1Value Evidence and Outcomes, GlaxoSmithKline, Uxbridge, United Kingdom, 2Adelphi Real World Ltd., Macclesfield, United Kingdom, 3Autoimmune, Adelphi Real World Ltd., Manchester, United Kingdom, 4Value Evidence and Outcomes, GlaxoSmithKline, Renaissance Centre, PA, 5Immuno-Inflammation Therapy Area, GlaxoSmithKline, Triangle Park, NC, 6US Medical Affairs, GlaxoSmithKline, Philadelphia, PA

    Background/Purpose: Patient and physician treatment satisfaction influences long-term adherence with a treatment regimen. The primary objective was to identify factors linked to satisfaction with the…
  • Abstract Number: 2248 • 2014 ACR/ARHP Annual Meeting

    Clinical Outcomes, Neuropathic Pain and Patient Satisfaction over a 15 Year Period Following Primary Tka: A Repeat-Cross-Sectional Analysis

    Anne Lübbeke1, Matthieu Zingg2, Daniel Fritschy1, Pierre Hoffmeyer1 and Hermes Miozzari2, 1Orthopaedic Surgery, Geneva University Hospitals, Geneva, Switzerland, 2Orthopaedics, Geneva University Hospitals, Geneva, Switzerland

    Background/Purpose Studies evaluating patient-reported long term outcomes (>10 years) after primary TKA are lacking. Moreover, variability in patient satisfaction after TKA has been reported for…
  • Abstract Number: 2273 • 2013 ACR/ARHP Annual Meeting

    Patient Survey Challenges Conventional Notions Regarding Symptoms and Experiences Of People Living With Rheumatoid Arthritis

    Kelly O'Neill Young1, Cynthia S. Crowson2 and Dana M. Symons1, 1Rheumatoid Patient Foundation, Cocoa, FL, 2Department of Health Sciences Research, Mayo Clinic, Rochester, MN

    Background/Purpose: While rheumatoid arthritis (RA) has been studied for decades, many aspects of the disease are not well understood. Like systemic lupus erythematosus, RA manifests…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology